技術指標
指標
數值
方向
MACD(12,26,9)
-0.028
中性
RSI(14)
62.378
中性
STOCH(KDJ)(9,3,3)
57.592
中性
ATR(14)
0.035
高波動
CCI(14)
110.765
買入
Williams %R
33.333
買入
TRIX(12,20)
0.025
賣出
StochRSI(14)
99.923
買入
搜尋
Organon & Co
OGN添加自選
13.550USD
+0.005+0.04%
收盤 07-31 16:00（美東）報價延遲15分鐘
3.53B總市值
14.35本益比TTM
關鍵數據
13.550今開
13.570最高
2.69M成交量
14.35本益比TTM
3.63本益比動
0.080股利TTM
1.03%換手率
13.550昨收
13.540最低
22.60M成交額
4.08本益比靜
4.69市淨率
0.59%股息率 TTM
1.88%ROA
13.48052週最高
1.11量比
864.00M淨利潤
260.32M總股本
0.9440每股盈餘TTM
1.53Beta
34.05%ROE
5.69052週最低
0.22%振幅
54.36%毛利率
3.53B總市值
-0.02回報/風險
3.01%風險率
TradingKey Organon & Co股票評分
單位: USD 更新時間: 2026-07-31操作建議
Organon & Co當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在藥品行業排名69/155位。機構持股佔比非常高，近一月多位分析師給出公司評級為持有。最高目標價為10.80。中期看，股價處於平穩狀態。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Organon & Co評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
Organon & Co亮點
亮點風險
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
高分紅
公司屬於高分紅公司，最新股息支付率34.38%
估值高估
公司最新PE估值14.35，處於3年歷史高位
機構減倉
最新機構持股239.27M股，環比減少1.64%
歐文·卡恩持倉
明星投資者歐文·卡恩持倉，最新持倉2.48M股
分析師目標
基於
6
分析師
持有
評級
10.800
目標均價
-20.24%
漲幅空間
Organon & Co新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
6
分析師
持有
評級
10.800
目標均價
-20.24%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
160
總數
6
中位數
9
平均值
公司名稱
評級分佈
分析師數
Organon & Co
OGN
6
Amgen Inc
AMGN
37
Biogen Inc
BIIB
37
Eli Lilly and Co
LLY
34
輝瑞
PFE
32
艾伯維
ABBV
32
1
2
3
...
32
技術指標
移動平均線
指標
數值
方向
MA5
13.540
買入
MA10
13.530
買入
MA20
13.517
買入
MA50
13.466
買入
MA100
11.375
買入
MA200
9.549
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Organon & Co簡介
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
公司代碼OGN
公司Organon & Co
CEOMorrissey (Joseph T)
網址https://www.organon.com/
公司股東
相關品種
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
Organon & Co(OGN)的當前股價是多少？
Organon & Co(OGN)的當前股價是 13.55。
Organon & Co 的股票代碼是什麼？
Organon & Co的股票代碼是OGN。
Organon & Co股票的52週最高點是多少？
Organon & Co股票的52週最高點是13.48。
Organon & Co股票的52週最低點是多少？
Organon & Co股票的52週最低點是5.69。
Organon & Co的市值是多少？
Organon & Co的市值是3.53B。
現在Organon & Co(OGN)的股票是買入、持有還是賣出？
根據分析師評級，Organon & Co(OGN)的總體評級為signal_hold，目標價格為10.80。
Organon & Co(OGN)股票的每股收益（EPS TTM）是多少
Organon & Co(OGN)股票的每股收益（EPS TTM）是0.72。